SFC Fluidics Inc. of Fayetteville announced Wednesday that it has been awarded $1.4 million in Phase II Small Business Innovation Research funding from the National Institutes of Health.
The company will use the funds to develop an implantable, wirelessly controlled, rapid dosing drug delivery system for small animal research. The device, called the min-ePump, will allow subject animals, such as rats, to be untethered, allowing more natural movement and behavior.
Research into substance abuse, mood disorders, Alzheimer's disease, Parkinson's disease, PTSD, depression and more could benefit from untethered animal behavior models.
